CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Handel 10x Genomics, Inc. - TXG CFD

    55.73
    7.23%
    0.14
    Lav: 53.18
    Høj: 56.09
    Market Trading Hours* (UTC) Opens on Monday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Opsummering
    • Historisk Data
    • Begivenheder
    • Resultatopgørelse
    • Saldo
    • Cash flow
    • Ejerskab
    Handelsbetingelser
    Spænd 0.14
    Long position, gebyr natten over

    Long position overnight fee

    Margin. Your investment $1,000.00
    Gebyr for natten over -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Gå til platform
    		-0.024874%
    Short position, gebyr natten over

    Short position overnight fee

    Margin. Your investment $1,000.00
    Gebyr for natten over 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Gå til platform
    		0.002651%
    Gebyr natten over, tid 21:00 (UTC)
    Min. handlet mængde 1
    Valuta USD
    Margen 20%
    Aktiebørs United States of America
    Kommission på handel 0%

    *Information provided by Capital.com

    Nøglestatistikker
    Tidligere luk* 51.97
    Åben* 53.18
    1-Års Ændring* -28.68%
    Dagens Spænd* 53.18 - 56.09
    52-Ugers Spænd 23.81-83.34
    Gennemsnitlig Volumen (10 dage) 754.85K
    Gennemsnitlig Volumen (3 måneder) 21.21M
    Market Cap 6.00B
    P/E-forhold -100.00K
    Udestående aktier 115.36M
    Omsætning 516.41M
    EPS -1.46
    Dividend (Udbytte %) N/A
    Beta 1.74
    Næste indtjeningsopgørelse May 2, 2023

    Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Luk Change Change (%) Åben High Low
    Mar 31, 2023 55.73 3.30 6.29% 52.43 56.16 52.01
    Mar 30, 2023 51.97 0.76 1.48% 51.21 52.32 51.07
    Mar 29, 2023 50.69 1.41 2.86% 49.28 50.98 49.00
    Mar 28, 2023 48.81 -0.45 -0.91% 49.26 49.42 48.27
    Mar 27, 2023 49.70 -0.68 -1.35% 50.38 51.52 49.29
    Mar 24, 2023 50.12 2.16 4.50% 47.96 50.30 47.65
    Mar 23, 2023 48.97 0.03 0.06% 48.94 51.49 48.48
    Mar 22, 2023 48.69 -1.39 -2.78% 50.08 51.08 48.61
    Mar 21, 2023 50.03 1.83 3.80% 48.20 50.25 47.91
    Mar 20, 2023 47.76 0.30 0.63% 47.46 48.56 46.76
    Mar 17, 2023 48.08 -1.09 -2.22% 49.17 49.71 47.66
    Mar 16, 2023 50.25 2.49 5.21% 47.76 50.90 47.60
    Mar 15, 2023 48.54 1.45 3.08% 47.09 49.32 47.08
    Mar 14, 2023 48.63 0.07 0.14% 48.56 49.52 48.06
    Mar 13, 2023 47.44 3.47 7.89% 43.97 49.32 43.97
    Mar 10, 2023 44.93 -1.55 -3.33% 46.48 46.49 43.15
    Mar 9, 2023 47.00 -1.65 -3.39% 48.65 49.98 46.93
    Mar 8, 2023 48.95 1.16 2.43% 47.79 49.49 47.24
    Mar 7, 2023 48.16 0.10 0.21% 48.06 49.75 47.48
    Mar 6, 2023 48.39 -2.30 -4.54% 50.69 50.80 48.13

    10x Genomics, Inc. Events

    Tid (UTC) (UTC) Land Begivenhed
    No events scheduled
    Se alle begivenheder
    • Årlig
    • Pr kvartal
    2022 2021 2020 2019 2018
    Total omsætning 516.409 490.49 298.845 245.893 146.313
    Omsætning 516.409 490.49 298.845 245.893 146.313
    Kost af omsætning, Total 120.386 74.091 58.468 61.033 28.661
    Bruttofortjeneste 396.023 416.399 240.377 184.86 117.652
    Totale Driftsudgifter 684.353 542.743 834.508 276.466 257.077
    Salgs/Generelle/Admin. Udgifter, Total 298.3 257.56 199.726 130.834 87.936
    Forskning & Udvikling 265.667 211.752 570.923 83.097 109.9
    Other Operating Expenses, Total 0 -0.66 1.27 1.502 30.58
    Driftsindtægter -167.944 -52.253 -535.663 -30.573 -110.764
    Renteindkomst (Udgift), Netto Ikke-Drift 6.171 -0.66 -0.15 -0.274 -1.385
    Andre, Netto -0.198 -0.802 1.337 -0.186 -0.249
    Netto Indkomst Før Skat -161.971 -53.715 -534.476 -31.033 -112.398
    Netto Indkomst Efter Skat -166 -58.223 -542.731 -31.251 -112.485
    Netto Indkomst Før Ekstra Ting -166 -58.223 -542.731 -31.251 -112.485
    Totale Ekstraordinære Ting
    Netto Indkomst -166 -58.223 -542.731 -31.251 -112.485
    Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -166 -58.223 -542.731 -31.251 -112.485
    Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -166 -58.223 -542.731 -31.251 -112.485
    Fortyndet Netto Indkomst -166 -58.223 -542.731 -31.251 -112.485
    Fortyndet Vægtet Gennemsnit Aktier 113.859 110.348 101.152 96.2416 93.8497
    Fortyndet EPS Uden Ekstraordinære Ting -1.45795 -0.52763 -5.36552 -0.32471 -1.19857
    Fortyndet Normaliseret EPS -1.45795 -0.52763 -5.33904 -0.32471 -1.19857
    Usædvanlig Udgift (Indkomst) 0 0 4.121
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total omsætning 156.232 131.072 114.609 114.496 143.53
    Omsætning 156.232 131.072 114.609 114.496 143.53
    Kost af omsætning, Total 36.827 30.377 27.704 25.478 27.598
    Bruttofortjeneste 119.405 100.695 86.905 89.018 115.932
    Totale Driftsudgifter 179.328 171.068 177.726 156.231 159.36
    Salgs/Generelle/Admin. Udgifter, Total 78.887 73.401 79.337 66.675 69.877
    Forskning & Udvikling 63.614 67.29 70.685 64.078 61.885
    Usædvanlig Udgift (Indkomst) 0 0
    Other Operating Expenses, Total 0 0 0 0
    Driftsindtægter -23.096 -39.996 -63.117 -41.735 -15.83
    Renteindkomst (Udgift), Netto Ikke-Drift 2.69 1.911 1.129 0.441 -0.168
    Andre, Netto 3.995 -1.95 -1.843 -0.4 0.005
    Netto Indkomst Før Skat -16.411 -40.035 -63.831 -41.694 -15.993
    Netto Indkomst Efter Skat -17.215 -41.914 -64.458 -42.413 -18.449
    Netto Indkomst Før Ekstra Ting -17.215 -41.914 -64.458 -42.413 -18.449
    Netto Indkomst -17.215 -41.914 -64.458 -42.413 -18.449
    Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -17.215 -41.914 -64.458 -42.413 -18.449
    Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -17.215 -41.914 -64.458 -42.413 -18.449
    Fortyndet Netto Indkomst -17.215 -41.914 -64.458 -42.413 -18.449
    Fortyndet Vægtet Gennemsnit Aktier 114.767 114.112 113.575 112.966 111.913
    Fortyndet EPS Uden Ekstraordinære Ting -0.15 -0.3673 -0.56754 -0.37545 -0.16485
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Fortyndet Normaliseret EPS -0.15 -0.3673 -0.56754 -0.37545 -0.16485
    • Årlig
    • Pr kvartal
    2021 2020 2019 2018 2017
    Totale Nuværende Aktiver 747.591 774.366 480.84 106.236 68.107
    Likvider og Kortsigtede Investeringer 587.447 663.603 424.166 65.08 47.857
    Likvider & Lignende 587.447 663.603 424.166 65.08 47.857
    Totale Tilgodehavender, Netto 85.254 51.208 33.371 29.566 13.341
    Accounts Receivable - Trade, Net 85.254 51.208 33.371 28.088 13.341
    Total Inventory 59.966 29.959 15.27 8.57 4.838
    Prepaid Expenses 13.896 13.029 8.033 3.02 2.071
    Total Assets 1018.83 929.341 605.923 124.31 75.609
    Property/Plant/Equipment, Total - Net 230.41 119.823 48.821 11.127 6.925
    Property/Plant/Equipment, Total - Gross 279.431 150.325 67.876 25.21 17.958
    Accumulated Depreciation, Total -49.021 -30.502 -19.055 -14.083 -11.033
    Other Long Term Assets, Total 10.917 12.798 76.262 6.947 0.577
    Total Current Liabilities 110.357 118.126 63.049 32.362 22.141
    Accounts Payable 17.351 4.709 13.028 8.792 5.443
    Accrued Expenses 75.821 92.326 30.035 12.118 8.959
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 9.882 4.187 4.224
    Other Current Liabilities, Total 17.185 21.091 10.104 7.265 3.515
    Total Liabilities 201.258 190.269 185.84 101.053 29.704
    Total Long Term Debt 0 0 19.837 25.489 6.335
    Long Term Debt 0 19.837 25.489 6.335
    Other Liabilities, Total 90.901 72.143 102.954 43.202 1.228
    Total Equity 817.568 739.072 420.083 23.257 45.905
    Redeemable Preferred Stock 0 243.244 158.414
    Common Stock 0.002 0.002 0.002 0.001 0.001
    Additional Paid-In Capital 1680.86 1544.22 682.494 11.165 6.136
    Retained Earnings (Accumulated Deficit) -863.321 -805.098 -262.367 -231.116 -118.631
    Other Equity, Total 0.022 -0.05 -0.046 -0.037 -0.015
    Total Liabilities & Shareholders’ Equity 1018.83 929.341 605.923 124.31 75.609
    Total Common Shares Outstanding 112.515 108.486 96.2416 93.8497 93.8497
    Other Current Assets, Total 1.028 16.567
    Intangibles, Net 25.397 22.354
    Goodwill, Net 4.511
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Totale Nuværende Aktiver 697.335 747.591 744.104 757.174 745.716
    Likvider og Kortsigtede Investeringer 539.323 587.447 600.44 621.958 617.195
    Likvider & Lignende 312.487 587.447 600.44 621.958 617.195
    Totale Tilgodehavender, Netto 76.526 85.254 78.43 59.68 57.408
    Accounts Receivable - Trade, Net 76.526 85.254 78.43 59.68 57.408
    Total Inventory 63.697 59.966 51.141 44.087 38.507
    Prepaid Expenses 17.762 13.896 14.065 13.298 14.442
    Other Current Assets, Total 0.027 1.028 0.028 18.151 18.164
    Total Assets 1003.25 1018.83 990.572 977.579 954.033
    Property/Plant/Equipment, Total - Net 265.88 230.41 203.304 176.454 163.666
    Property/Plant/Equipment, Total - Gross 279.431 247.698 215.665 198.415
    Accumulated Depreciation, Total -49.021 -44.394 -39.211 -34.749
    Goodwill, Net 4.511 4.511 4.511 4.511 4.511
    Intangibles, Net 24.764 25.397 26.041 26.693 27.342
    Other Long Term Assets, Total 10.761 10.917 12.612 12.747 12.798
    Total Current Liabilities 94.446 110.357 100.375 113.126 120.549
    Accounts Payable 18.956 17.351 17.037 16.181 15.578
    Accrued Expenses 59.913 75.821 69.92 85.598 95.307
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 15.577 17.185 13.418 11.347 9.664
    Total Liabilities 196.566 201.258 190.351 192.993 201.573
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt 0
    Other Liabilities, Total 102.12 90.901 89.976 79.867 81.024
    Total Equity 806.685 817.568 800.221 784.586 752.46
    Common Stock 0.002 0.002 0.002 0.002 0.002
    Additional Paid-In Capital 1714.86 1680.86 1644.9 1612.23 1569.06
    Retained Earnings (Accumulated Deficit) -905.734 -863.321 -844.872 -827.701 -816.649
    Other Equity, Total -2.443 0.022 0.194 0.058 0.048
    Total Liabilities & Shareholders’ Equity 1003.25 1018.83 990.572 977.579 954.033
    Total Common Shares Outstanding 113.276 112.515 111.537 110.74 109.589
    Kortsigtede Investeringer 226.836
    • Årlig
    • Pr kvartal
    2021 2020 2019 2018 2017
    Netto indkomst/Startlinje -58.223 -542.731 -31.251 -112.485 -18.762
    Likvider Fra Driftsaktiviteter -21.373 -217.898 34.627 -76.409 -10.699
    Likvider Fra Driftsaktiviteter 21.118 14.012 7.066 3.905 4.305
    Ikke-Likvide Ting 103.177 361.202 14.048 4.156 1.81
    Cash Taxes Paid 8.66 0.28 -0.022 -0.006 0
    Likvid Rente Betalt 1.222 1.67 2.25 1.824 0.658
    Ændringer i Driftskapital -87.445 -50.381 44.764 28.015 1.948
    Likvider fra Investeringsaktiviteter -106.729 -38.394 -42.767 -6.709 -3.756
    Kapitaludgifter -101.278 -38.394 -42.767 -6.709 -3.756
    Likvider fra Financieringsaktiviteter 35.297 468.906 414.59 105.367 20.583
    Financiering af Cash-Flow-Ting -5.028 -5.848 0 0
    Udstedelse (Pensionering) af Aktier, Netto 40.325 506.01 414.59 86.628 20.976
    Udstedelse (Pensionering) af Gæld, Netto 0 -31.256 0 18.739 -0.393
    Udenlandsk Børs Effekter 0.234 -0.463 -0.045 -0.018 -0.014
    Netto Ændring i Likviditet -92.571 212.151 406.405 22.231 6.114
    Andre Investerings-Cash-Flow-Ting, Total -5.451
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -42.413 -58.223 -39.774 -22.603 -11.551
    Cash From Operating Activities -20.802 -21.373 -27.178 -0.962 -4.082
    Cash From Operating Activities 6.191 21.118 15.337 9.641 4.752
    Non-Cash Items 28.014 103.177 74.717 47.188 17.922
    Cash Taxes Paid 2.9 8.66 8.318 7.838 6.822
    Cash Interest Paid 0.841 1.222 1.222 1.222 1.222
    Changes in Working Capital -12.594 -87.445 -77.458 -35.188 -15.205
    Cash From Investing Activities -257.558 -106.729 -79.111 -58.884 -44.316
    Capital Expenditures -28.136 -101.278 -73.66 -53.433 -38.865
    Other Investing Cash Flow Items, Total -229.422 -5.451 -5.451 -5.451 -5.451
    Cash From Financing Activities 2.417 35.297 26.394 19.711 3.518
    Financing Cash Flow Items -5.409 -5.028 -5.028 -5.028 -5.028
    Issuance (Retirement) of Stock, Net 7.826 40.325 31.422 24.739 8.546
    Issuance (Retirement) of Debt, Net 0 0 0 0
    Foreign Exchange Effects -0.018 0.234 0.316 0.199 0.193
    Net Change in Cash -275.961 -92.571 -79.579 -39.936 -44.687
    Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
    Morgan Stanley Investment Management Inc. (US) Investment Advisor/Hedge Fund 9.4813 9210082 -415196 2022-12-31 LOW
    Baillie Gifford & Co. Investment Advisor 8.8556 8602235 158847 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.6523 8404774 145652 2022-12-31 LOW
    Paladin Capital Management, LLC Investment Advisor 8.3511 8112208 0 2022-03-31
    ARK Investment Management LLC Investment Advisor 4.4437 4316567 -260247 2022-12-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 4.3422 4217954 207975 2022-12-31 LOW
    Sands Capital Management, LLC Investment Advisor 3.3012 3206783 -184394 2022-12-31 LOW
    Fidelity Management & Research Company LLC Investment Advisor 3.2549 3161803 -518131 2022-12-31 LOW
    SRS Investment Management, LLC Hedge Fund 3.0939 3005427 0 2022-12-31 LOW
    Generation Investment Management LLP Investment Advisor/Hedge Fund 2.6231 2548100 -57577 2022-12-31 LOW
    Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 2.2421 2177988 -29270 2022-12-31 LOW
    Credit Suisse Asset Management Investment Advisor/Hedge Fund 2.1979 2135038 -17833 2022-12-31 LOW
    T. Rowe Price Associates, Inc. Investment Advisor 2.018 1960300 -337642 2022-12-31 LOW
    Citadel Advisors LLC Hedge Fund 1.507 1463901 1108820 2022-12-31 HIGH
    Brown Capital Management, LLC Investment Advisor 1.4964 1453630 -161463 2022-12-31 LOW
    Foresite Capital Management, LLC Private Equity 1.3985 1358528 -1145000 2022-12-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3854 1345749 -18168 2022-12-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3601 1321234 63324 2022-12-31 LOW
    Millennium Management LLC Hedge Fund 1.2491 1213394 999487 2022-12-31 HIGH
    JP Morgan Asset Management Investment Advisor 1.2158 1180996 27291 2022-12-31 LOW

    Hvorfor vælge Capital.com? Vores tal taler for sig selv.

    Capital.com Group

    500K+

    Handlende

    92K+

    Månedlkige, aktive klienter

    $53M+

    Månedlig investeringsvolumen

    $30M+

    Hævet hver måned

    Handelslommeregner

    Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

    Handelskurtage
    0
    • 1:1
    Gearing
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investering
    Handelsstørrelse (Gearing x Investering):
    Åben

    Luk

    Short Long
    Tidligere resultater er ikke en pålidelig indikator for fremtidige resultater
    Fortjeneste/Tab

    10x Genomics, Inc. Company profile

    Om 10x Genomics, Inc.

    10x Genomics, Inc. er en virksomhed inden for life science-teknologi. Virksomhedens integrerede løsninger omfatter instrumenter, forbrugsvarer og software til analyse af biologiske systemer. Dens produkter omfatter Chromium Single Cell Gene Expression, Single Cell Immune Profiling, Single Cell assay for transposase accessible chromatin (ATAC) + Gene Expression, Single Cell ATAC, Spatial Gene Expression, Spatial Gene Expression, Spatial Multiomics, og Targeted Gene Expression. Dens instrumenter omfatter Chromium X Series, Chromium Connect og Chromium Controller. Dens teknologi Next GEM-teknologi, som omfatter chips og kompatible reagenser, der tilbydes til single cell-produktporteføljen. Dens portefølje af forbrugsstoffer omfatter mikrofluidiske chips, objektglas, reagenser og andre forbrugsstoffer til både Visium- og Chromium-løsninger. Selskabets applikationer omfatter CRISPR-screening (Clustered Regular Interspaced Short Palindromic Repeats), multiomisk cytometri og kortlægning af immunreceptorer.

    Industry: Laboratory Diagnostic & Testing Substances

    6230 Stoneridge Mall Road
    PLEASANTON
    CALIFORNIA 94588
    US

    Resultatopgørelse

    • Annual
    • Quarterly

    Folk ser også

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Long position, gebyr natten over -0.0249%
    Short position, gebyr natten over 0.0027%
    Gebyr natten over, tid 21:00 (UTC)
    Spænd 3.0

    BTC/USD

    28,561.95 Price
    +0.540% 1D Chg, %
    Long position, gebyr natten over -0.0616%
    Short position, gebyr natten over 0.0137%
    Gebyr natten over, tid 21:00 (UTC)
    Spænd 60.00

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    Long position, gebyr natten over -0.4092%
    Short position, gebyr natten over 0.3873%
    Gebyr natten over, tid 21:00 (UTC)
    Spænd 0.005

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Long position, gebyr natten over -0.0156%
    Short position, gebyr natten over -0.0063%
    Gebyr natten over, tid 21:00 (UTC)
    Spænd 0.03

    Leder du stadig efter en mægler, du kan stole på?

    Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com

    1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel